0020

COM:SKHB

上海科华生物工程股份有限公司

  • Stock

Last Close

6.85

22/11 07:04

Market Cap

2.75B

Beta: -

Volume Today

8.31M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
196.04M
-
249.52M
27.28%
288.87M
15.77%
307.94M
6.60%
354.08M
14.98%
450.55M
27.24%
527.53M
17.09%
650.94M
23.39%
792.31M
21.72%
1.05B
32.09%
1.12B
7.10%
average payables
55.00M
-
61.16M
11.20%
71.69M
17.21%
78.84M
9.98%
124.62M
58.06%
155.44M
24.73%
178.51M
14.85%
259.57M
45.41%
314.65M
21.22%
569.75M
81.07%
577.71M
1.40%
average receivables
203.80M
-
233.66M
14.65%
299.07M
28.00%
389.95M
30.39%
515.98M
32.32%
662.84M
28.46%
759.35M
14.56%
910.31M
19.88%
1.15B
26.24%
1.44B
25.29%
1.43B
0.96%
book value per share
2.30
-
2.55
11.00%
3.31
29.64%
3.60
8.75%
3.90
8.27%
4.25
9.02%
4.59
8.17%
6.21
35.07%
7.53
21.39%
9.36
24.27%
7.84
16.31%
capex per share
-0.18
-
-0.20
16.55%
-0.17
17.22%
-0.20
19.00%
-0.21
1.80%
-0.24
17.97%
-0.27
12.99%
-0.51
86.32%
-0.42
17.47%
-0.83
97.96%
-0.64
22.67%
capex to depreciation
-3.22
-
-3.08
4.43%
-2.02
34.61%
-1.64
18.48%
-1.52
7.47%
-1.44
5.58%
-1.16
19.00%
-1.93
65.69%
-1.41
26.78%
-2.01
42.21%
-1.46
27.08%
capex to operating cash flow
-0.35
-
-0.40
16.82%
-0.38
5.34%
-0.37
3.83%
-0.80
119.07%
-0.98
21.60%
-0.56
42.39%
-0.19
66.54%
-0.20
6.19%
-0.20
0.74%
0.70
450.72%
capex to revenue
-0.08
-
-0.08
6.65%
-0.07
10.38%
-0.07
0.21%
-0.07
10.80%
-0.06
5.53%
-0.06
6.78%
-0.06
6.80%
-0.04
28.25%
-0.06
37.96%
-0.14
123.33%
cash per share
0.96
-
0.77
19.66%
1.29
66.22%
1.55
20.73%
1.34
13.44%
0.96
28.88%
0.86
9.79%
4.16
382.75%
5.04
21.08%
6.76
34.05%
3.79
43.95%
days of inventory on hand
140.05
-
154.15
10.07%
162.61
5.49%
142.57
12.33%
152.20
6.76%
158.45
4.10%
146.81
7.34%
159.59
8.70%
136.77
14.29%
139.77
2.19%
233.85
67.31%
days payables outstanding
30.23
-
41.31
36.66%
37.32
9.66%
40.04
7.30%
62.38
55.79%
46.81
24.96%
55.60
18.76%
65.94
18.59%
52.31
20.67%
90.87
73.73%
79.63
12.38%
days sales outstanding
72.97
-
73.28
0.42%
111.68
52.41%
111.40
0.26%
138.69
24.50%
132.04
4.79%
120.74
8.55%
89.76
25.66%
95.98
6.93%
83.95
12.53%
188.87
124.97%
debt to assets
0.03
-
0.02
34.33%
0.02
14.41%
0.10
445.52%
0.13
27.23%
0.18
39.06%
0.13
31.47%
0.10
22.29%
0.15
54.11%
debt to equity
0.03
-
0.02
33.18%
0.03
23.52%
0.17
545.75%
0.21
24.27%
0.35
68.37%
0.23
35.32%
0.18
20.80%
0.26
42.24%
dividend yield
0.02
-
0.01
49.87%
0.01
35.75%
0.01
11.01%
0.01
62.95%
0.01
12.91%
0.01
13.34%
0.01
16.32%
0.02
33.24%
0.01
45.51%
0.05
525.99%
earnings yield
0.03
-
0.03
19.66%
0.01
48.85%
0.02
58.43%
0.03
36.48%
0.04
41.50%
0.05
4.22%
0.15
220.78%
0.18
21.27%
0.27
53.33%
-0.04
114.69%
enterprise value
7.81B
-
10.06B
28.82%
14.12B
40.44%
9.54B
32.42%
6.40B
32.92%
4.62B
27.80%
6.04B
30.71%
6.76B
11.83%
5.87B
13.11%
3.75B
36.06%
5.29B
40.91%
enterprise value over ebitda
20.06
-
25.88
28.97%
48.94
89.13%
27.63
43.55%
17.96
35.00%
11.15
37.90%
11.95
7.20%
4.16
65.22%
3.05
26.56%
1.41
53.77%
64.92
4,498.80%
ev to operating cash flow
31.20
-
40.28
29.12%
62.96
56.30%
33.93
46.11%
48.97
44.33%
36.45
25.57%
24.27
33.41%
4.94
79.64%
5.44
10.07%
1.74
67.96%
-11.14
739.04%
ev to sales
7.00
-
8.26
17.88%
12.22
47.98%
6.83
44.08%
4.02
41.23%
2.32
42.17%
2.50
7.75%
1.63
35.02%
1.21
25.62%
0.54
55.47%
2.19
306.94%
free cash flow per share
0.33
-
0.30
9.08%
0.27
9.40%
0.35
26.67%
0.05
85.62%
0.01
89.03%
0.21
3,767.51%
2.19
934.97%
1.68
23.39%
3.36
99.81%
-1.57
146.69%
free cash flow yield
0.02
-
0.01
27.86%
0.01
34.00%
0.02
84.30%
0.00
79.06%
0.00
83.74%
0.02
2,966.20%
0.14
683.95%
0.11
20.40%
0.27
139.70%
-0.14
150.75%
graham net net
1.20
-
1.10
7.80%
1.42
28.86%
1.66
17.00%
1.37
17.64%
0.41
69.84%
0.58
41.21%
2.32
297.81%
4.16
79.29%
4.57
9.84%
2.81
38.53%
graham number
5.51
-
5.84
6.02%
5.57
4.60%
6.06
8.82%
6.10
0.72%
6.22
2.00%
7.42
19.25%
17.75
139.17%
21.13
19.03%
26.63
26.03%
8.96
66.37%
income quality
0.83
-
0.83
0.21%
1.07
28.50%
1.22
14.00%
0.59
51.55%
0.51
12.98%
0.91
77.20%
1.20
31.49%
0.80
33.40%
1.24
56.04%
2.03
63.14%
intangibles to total assets
0.11
-
0.12
8.94%
0.20
60.66%
0.19
2.71%
0.23
19.31%
0.37
60.84%
0.35
3.74%
0.22
38.30%
0.19
14.74%
0.14
25.35%
0.18
28.62%
interest coverage
169.60
-
-24.02
-
67.59
381.42%
70.62
4.48%
23.63
66.54%
12.33
47.83%
38.84
215.04%
20.67
46.78%
51.55
149.41%
-3.31
106.42%
interest debt per share
0.00
-
0.08
-
0.08
1.81%
0.11
30.52%
0.74
579.79%
1.01
37.06%
2.25
122.43%
1.87
17.03%
1.76
5.56%
2.09
18.60%
inventory turnover
2.61
-
2.37
9.15%
2.24
5.20%
2.56
14.06%
2.40
6.33%
2.30
3.94%
2.49
7.92%
2.29
8.00%
2.67
16.68%
2.61
2.14%
1.56
40.23%
invested capital
0.03
-
0.02
33.18%
0.03
23.52%
0.17
545.75%
0.21
24.27%
0.35
68.37%
0.23
35.32%
0.18
20.80%
0.26
42.24%
market cap
8.28B
-
10.44B
26.04%
14.72B
41.04%
10.25B
30.35%
7.04B
31.34%
4.75B
32.57%
5.99B
26.25%
7.80B
30.24%
7.63B
2.26%
6.36B
16.59%
5.85B
8.00%
net current asset value
754.18M
-
753.97M
0.03%
958.62M
27.14%
1.08B
12.50%
1.07B
0.90%
683.90M
36.01%
805.31M
17.75%
1.93B
139.71%
2.98B
54.46%
3.48B
16.85%
2.39B
31.45%
net debt to ebitda
-1.22
-
-0.98
19.57%
-2.07
111.36%
-2.05
0.97%
-1.79
12.90%
-0.30
83.21%
0.10
132.59%
-0.65
759.65%
-0.91
41.75%
-0.98
7.29%
-6.93
605.88%
net income per share
0.59
-
0.59
1.26%
0.42
29.79%
0.45
8.89%
0.42
6.31%
0.41
4.57%
0.53
31.46%
2.26
323.49%
2.63
16.71%
3.37
27.81%
-0.46
113.52%
operating cash flow per share
0.51
-
0.51
0.23%
0.44
12.56%
0.55
23.74%
0.25
53.53%
0.25
2.98%
0.49
96.11%
2.70
456.86%
2.10
22.28%
4.19
99.44%
-0.92
122.05%
payables turnover
12.07
-
8.83
26.83%
9.78
10.70%
9.11
6.80%
5.85
35.81%
7.80
33.26%
6.56
15.80%
5.54
15.68%
6.98
26.05%
4.02
42.44%
4.58
14.12%
receivables turnover
5.00
-
4.98
0.41%
3.27
34.39%
3.28
0.26%
2.63
19.68%
2.76
5.03%
3.02
9.35%
4.07
34.52%
3.80
6.48%
4.35
14.33%
1.93
55.55%
research and ddevelopement to revenue
0.02
-
0.02
18.33%
0.03
33.28%
0.02
21.51%
0.02
2.38%
0.02
5.91%
0.03
28.31%
0.04
30.02%
0.03
13.50%
0.04
17.50%
0.09
152.45%
return on tangible assets
0.24
-
0.23
1.79%
0.13
45.62%
0.12
2.26%
0.10
15.99%
0.09
9.76%
0.11
21.79%
0.24
113.99%
0.24
2.17%
0.23
4.61%
-0.04
118.35%
revenue per share
2.26
-
2.47
9.28%
2.28
7.64%
2.72
19.25%
3.11
14.13%
3.88
24.87%
4.71
21.21%
8.21
74.46%
9.44
15.02%
13.55
43.50%
4.69
65.37%
roe
0.25
-
0.23
8.77%
0.13
45.84%
0.13
0.12%
0.11
13.46%
0.10
12.46%
0.12
21.54%
0.36
213.52%
0.35
3.86%
0.36
2.85%
-0.06
116.15%
roic
0.25
-
0.23
8.28%
0.12
48.45%
0.12
0.90%
0.11
8.47%
0.10
8.37%
0.10
0.29%
0.27
177.74%
0.28
5.31%
0.30
6.90%
-0.03
108.94%
sales general and administrative to revenue
0.01
-
0.01
36.90%
0.02
32.44%
0.01
36.45%
0.02
76.66%
0.03
75.40%
0.03
1.57%
0.02
32.52%
-0.02
202.01%
0.03
249.36%
0.05
45.54%
shareholders equity per share
2.30
-
2.55
11.00%
3.31
29.64%
3.60
8.75%
3.90
8.27%
4.25
9.02%
4.59
8.17%
6.21
35.07%
7.53
21.39%
9.36
24.27%
7.84
16.31%
stock based compensation to revenue
-0.46
-
tangible asset value
1.05B
-
1.09B
3.66%
1.32B
20.59%
1.46B
10.47%
1.46B
0.18%
1.14B
21.76%
1.38B
20.82%
2.59B
88.14%
3.83B
47.93%
4.63B
20.62%
3.66B
20.84%
tangible book value per share
2.14
-
2.22
3.66%
2.60
17.36%
2.84
9.01%
2.84
0.17%
2.23
21.75%
2.69
20.71%
5.12
90.71%
7.46
45.66%
8.99
20.55%
7.12
20.85%
working capital
765.79M
-
764.88M
0.12%
1.05B
36.65%
1.17B
11.85%
1.18B
1.36%
1.01B
14.96%
1.17B
16.06%
2.75B
135.07%
3.81B
38.67%
4.39B
15.22%
3.41B
22.29%

All numbers in (except ratios and percentages)